Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126966162	12696616	2	F	20160313	20160822	20160830	20160909	EXP		CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070753	BRISTOL MYERS SQUIBB		30.77	YR		M	Y	66.00000	KG	20160909		CN	CN	CN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126966162	12696616	1	PS	EFAVIRENZ	EFAVIRENZ	1	Oral	600 MG, QD	3600	MG	U	U	825A15173	21360	600	MG	TABLET	QD
126966162	12696616	2	SS	TENOFOVIR	TENOFOVIR	1	Unknown	UNK			U			0
126966162	12696616	3	SS	LAMIVUDINE.	LAMIVUDINE	1	Unknown	UNK			U	N		0

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126966162	12696616	1	Acquired immunodeficiency syndrome
126966162	12696616	2	Acquired immunodeficiency syndrome
126966162	12696616	3	Acquired immunodeficiency syndrome

Outcome of event

Event ID	CASEID	OUTC COD
126966162	12696616	HO

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
126966162	12696616		Rash

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
126966162	12696616	1	20160308	20160331
126966162	12696616	2	20160308
126966162	12696616	3	20160308